US6040138A
(en)
|
1995-09-15 |
2000-03-21 |
Affymetrix, Inc. |
Expression monitoring by hybridization to high density oligonucleotide arrays
|
US5470705A
(en)
*
|
1992-04-03 |
1995-11-28 |
Applied Biosystems, Inc. |
Probe composition containing a binding domain and polymer chain and methods of use
|
ATE173767T1
(de)
*
|
1992-04-03 |
1998-12-15 |
Perkin Elmer Corp |
Proben zusammensetzung und verfahren
|
US5605798A
(en)
|
1993-01-07 |
1997-02-25 |
Sequenom, Inc. |
DNA diagnostic based on mass spectrometry
|
JP3419850B2
(ja)
*
|
1993-10-26 |
2003-06-23 |
株式会社日立製作所 |
核酸分別方法
|
US5976798A
(en)
*
|
1994-03-30 |
1999-11-02 |
Mitokor |
Methods for detecting mitochondrial mutations diagnostic for Alzheimer's disease and methods for determining heteroplasmy of mitochondrial nucleic acid
|
BR9507343A
(pt)
*
|
1994-04-04 |
1997-09-16 |
Ciba Corning Diagnostics Corp |
Testes de hibridização - ligação para a detecção de sequências de ácido nucléico específicas
|
US7323298B1
(en)
|
1994-06-17 |
2008-01-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Microarray for determining the relative abundances of polynuceotide sequences
|
US5807522A
(en)
*
|
1994-06-17 |
1998-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for fabricating microarrays of biological samples
|
US7378236B1
(en)
|
1994-06-17 |
2008-05-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method for analyzing gene expression patterns
|
US5849483A
(en)
*
|
1994-07-28 |
1998-12-15 |
Ig Laboratories, Inc. |
High throughput screening method for sequences or genetic alterations in nucleic acids
|
US5834181A
(en)
*
|
1994-07-28 |
1998-11-10 |
Genzyme Corporation |
High throughput screening method for sequences or genetic alterations in nucleic acids
|
ATE226983T1
(de)
*
|
1994-08-19 |
2002-11-15 |
Pe Corp Ny |
Gekoppeltes ampflikation- und ligationverfahren
|
GB9417211D0
(en)
*
|
1994-08-25 |
1994-10-12 |
Solicitor For The Affairs Of H |
Nucleotide sequencing method
|
USRE43097E1
(en)
|
1994-10-13 |
2012-01-10 |
Illumina, Inc. |
Massively parallel signature sequencing by ligation of encoded adaptors
|
US6280935B1
(en)
|
1994-10-13 |
2001-08-28 |
Lynx Therapeutics, Inc. |
Method of detecting the presence or absence of a plurality of target sequences using oligonucleotide tags
|
US5846719A
(en)
*
|
1994-10-13 |
1998-12-08 |
Lynx Therapeutics, Inc. |
Oligonucleotide tags for sorting and identification
|
US8236493B2
(en)
*
|
1994-10-21 |
2012-08-07 |
Affymetrix, Inc. |
Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
|
DE19508366C2
(de)
*
|
1995-03-10 |
1998-01-29 |
Evotec Biosystems Gmbh |
Verfahren zum direkten Nachweisen weniger Nucleinsäurestränge
|
US5630924A
(en)
*
|
1995-04-20 |
1997-05-20 |
Perseptive Biosystems, Inc. |
Compositions, methods and apparatus for ultrafast electroseparation analysis
|
US5830655A
(en)
|
1995-05-22 |
1998-11-03 |
Sri International |
Oligonucleotide sizing using cleavable primers
|
WO1996041011A1
(en)
*
|
1995-06-07 |
1996-12-19 |
Lynx Therapeutics, Inc. |
Oligonucleotide tags for sorting and identification
|
EP0880598A4
(de)
*
|
1996-01-23 |
2005-02-23 |
Affymetrix Inc |
Verfahren zur analyse von nukleinsäure
|
US6312893B1
(en)
|
1996-01-23 |
2001-11-06 |
Qiagen Genomics, Inc. |
Methods and compositions for determining the sequence of nucleic acid molecules
|
US6613508B1
(en)
|
1996-01-23 |
2003-09-02 |
Qiagen Genomics, Inc. |
Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques
|
US6027890A
(en)
|
1996-01-23 |
2000-02-22 |
Rapigene, Inc. |
Methods and compositions for enhancing sensitivity in the analysis of biological-based assays
|
US6706471B1
(en)
*
|
1996-01-24 |
2004-03-16 |
Third Wave Technologies, Inc. |
Detection of nucleic acid sequences by invader-directed cleavage
|
US6852487B1
(en)
|
1996-02-09 |
2005-02-08 |
Cornell Research Foundation, Inc. |
Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
|
US6020481A
(en)
*
|
1996-04-01 |
2000-02-01 |
The Perkin-Elmer Corporation |
Asymmetric benzoxanthene dyes
|
EP0912761A4
(de)
|
1996-05-29 |
2004-06-09 |
Cornell Res Foundation Inc |
Bestimmung von unterschieden in der nukleisäuresequenz mittels einer kombination von ligasebestimmung und polymerase-kettenreaktion
|
US6780982B2
(en)
*
|
1996-07-12 |
2004-08-24 |
Third Wave Technologies, Inc. |
Charge tags and the separation of nucleic acid molecules
|
JP4000605B2
(ja)
|
1996-07-24 |
2007-10-31 |
株式会社日立製作所 |
Dna試料調整装置及びこれを用いる電気泳動分析装置
|
WO1998010097A2
(en)
*
|
1996-09-03 |
1998-03-12 |
Pioneer Hi-Bred International, Inc. |
Method and apparatus for single molecule two color fluorescent detection and molecular weight and concentration determination
|
US6133436A
(en)
|
1996-11-06 |
2000-10-17 |
Sequenom, Inc. |
Beads bound to a solid support and to nucleic acids
|
WO1998026095A1
(en)
|
1996-12-10 |
1998-06-18 |
Genetrace Systems Inc. |
Releasable nonvolatile mass-label molecules
|
US6299881B1
(en)
*
|
1997-03-24 |
2001-10-09 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
|
US20030013115A1
(en)
*
|
1997-06-16 |
2003-01-16 |
Diversa Corporation, A Delaware Corporation |
Capillary array-based sample screening
|
US20020015997A1
(en)
*
|
1997-06-16 |
2002-02-07 |
Lafferty William Michael |
Capillary array-based sample screening
|
JP3938982B2
(ja)
*
|
1997-08-29 |
2007-06-27 |
オリンパス株式会社 |
Dnaキャピラリィ
|
US6559296B2
(en)
|
1997-08-29 |
2003-05-06 |
Olympus Optical Co., Ltd. |
DNA capillary
|
US6008379A
(en)
|
1997-10-01 |
1999-12-28 |
The Perkin-Elmer Corporation |
Aromatic-substituted xanthene dyes
|
US6583168B1
(en)
|
1997-11-25 |
2003-06-24 |
Applera Corporation |
Sulfonated diarylrhodamine dyes
|
US5936087A
(en)
|
1997-11-25 |
1999-08-10 |
The Perkin-Elmer Corporation |
Dibenzorhodamine dyes
|
US6087102A
(en)
|
1998-01-07 |
2000-07-11 |
Clontech Laboratories, Inc. |
Polymeric arrays and methods for their use in binding assays
|
EP1068356B8
(de)
*
|
1998-04-03 |
2007-01-03 |
Adnexus Therapeutics, Inc. |
Adressierbare protein arrays
|
US6096875A
(en)
|
1998-05-29 |
2000-08-01 |
The Perlein-Elmer Corporation |
Nucleotide compounds including a rigid linker
|
US6552167B1
(en)
*
|
1998-08-28 |
2003-04-22 |
Gryphon Therapeutics, Inc. |
Polyamide chains of precise length
|
US6238565B1
(en)
*
|
1998-09-16 |
2001-05-29 |
Varian, Inc. |
Monolithic matrix for separating bio-organic molecules
|
US7135284B1
(en)
*
|
1999-02-05 |
2006-11-14 |
Integrated Dna Technologies, Inc. |
Primer extension methods for production of high specific activity nucleic acid probes
|
US6635419B1
(en)
*
|
1999-02-16 |
2003-10-21 |
Applera Corporation |
Polynucleotide sequencing method
|
EP1161563A2
(de)
*
|
1999-03-15 |
2001-12-12 |
PE Corporation (NY) |
Nachweis multiplexer nukleinsäuren mittels bildung von sonde/mobilitätveränderungs-komplexen
|
US6506594B1
(en)
|
1999-03-19 |
2003-01-14 |
Cornell Res Foundation Inc |
Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
|
US7014994B1
(en)
|
1999-03-19 |
2006-03-21 |
Cornell Research Foundation,Inc. |
Coupled polymerase chain reaction-restriction-endonuclease digestion-ligase detection reaction process
|
US6514700B1
(en)
|
1999-04-30 |
2003-02-04 |
Aclara Biosciences, Inc. |
Nucleic acid detection using degradation of a tagged sequence
|
US20040248150A1
(en)
*
|
1999-04-02 |
2004-12-09 |
Sharat Singh |
Methods employing oligonucleotide-binding e-tag probes
|
US6627400B1
(en)
|
1999-04-30 |
2003-09-30 |
Aclara Biosciences, Inc. |
Multiplexed measurement of membrane protein populations
|
US6322980B1
(en)
|
1999-04-30 |
2001-11-27 |
Aclara Biosciences, Inc. |
Single nucleotide detection using degradation of a fluorescent sequence
|
US20030235832A1
(en)
*
|
2000-06-21 |
2003-12-25 |
Ahmed Chenna |
Multiplexed analysis by chromatographic separation of molecular tags
|
US7001725B2
(en)
|
1999-04-30 |
2006-02-21 |
Aclara Biosciences, Inc. |
Kits employing generalized target-binding e-tag probes
|
US6649351B2
(en)
|
1999-04-30 |
2003-11-18 |
Aclara Biosciences, Inc. |
Methods for detecting a plurality of analytes by mass spectrometry
|
US6673550B2
(en)
|
1999-04-30 |
2004-01-06 |
Aclara Biosciences, Inc. |
Electrophoretic tag reagents comprising fluorescent compounds
|
US7037654B2
(en)
|
1999-04-30 |
2006-05-02 |
Aclara Biosciences, Inc. |
Methods and compositions for enhancing detection in determinations employing cleavable electrophoretic tag reagents
|
DE19924606A1
(de)
*
|
1999-05-28 |
2000-11-30 |
Graffinity Pharm Design Gmbh |
Ligand-Anker-Konjugate
|
US20020045182A1
(en)
*
|
1999-07-16 |
2002-04-18 |
Lynx Therapeutics, Inc. |
Multiplexed differential displacement for nucleic acid determinations
|
EP1136568A4
(de)
*
|
1999-10-04 |
2004-12-15 |
Olympus Optical Corp Ltd |
Methode zum ermitteln der nukleinsäure
|
US7668658B2
(en)
|
1999-10-13 |
2010-02-23 |
Sequenom, Inc. |
Methods for generating databases and databases for identifying polymorphic genetic markers
|
EP1136569A3
(de)
|
2000-03-24 |
2004-01-28 |
Bayer Corporation |
Nukleinsäuresonden, die hoch-hydrophile nicht-nukleosidische Gruppen mit multiplen Markern enthalten und ihre Verwendungen
|
AU2001293366A1
(en)
|
2000-04-14 |
2001-10-30 |
Cornell Research Foundation, Inc. |
Method of designing addressable array for detection of nucleic acid sequence differences using ligase detection reaction
|
US6329801B1
(en)
*
|
2000-04-24 |
2001-12-11 |
Volterra Semiconductor Corporation |
Switching regulator control system and method
|
US20040067498A1
(en)
*
|
2000-04-28 |
2004-04-08 |
Ahmed Chenna |
Detection of nucleic acid sequences by cleavage and separation of tag-containing structures
|
US7771929B2
(en)
*
|
2000-04-28 |
2010-08-10 |
Monogram Biosciences, Inc. |
Tag library compounds, compositions, kits and methods of use
|
US7160735B2
(en)
*
|
2000-04-28 |
2007-01-09 |
Monogram Biosciences, Inc. |
Tagged microparticle compositions and methods
|
US20030207300A1
(en)
*
|
2000-04-28 |
2003-11-06 |
Matray Tracy J. |
Multiplex analytical platform using molecular tags
|
US20030170734A1
(en)
*
|
2000-04-28 |
2003-09-11 |
Stephen Williams |
Multiplexed assays using electrophoretically separated molecular tags
|
US7537938B2
(en)
*
|
2000-04-28 |
2009-05-26 |
Monogram Biosciences, Inc. |
Biomarker detection in circulating cells
|
AU6299401A
(en)
*
|
2000-05-08 |
2001-11-20 |
Qtl Biosystems Llc |
Improvements to the fluorescent polymer-qtl approach to biosensing
|
CA2410950A1
(en)
*
|
2000-05-30 |
2001-12-06 |
Hans-Michael Wenz |
Methods for detecting target nucleic acids using coupled ligation and amplification
|
US6887664B2
(en)
|
2000-06-06 |
2005-05-03 |
Applera Corporation |
Asynchronous primed PCR
|
US6632606B1
(en)
|
2000-06-12 |
2003-10-14 |
Aclara Biosciences, Inc. |
Methods for single nucleotide polymorphism detection
|
US6958214B2
(en)
|
2000-07-10 |
2005-10-25 |
Sequenom, Inc. |
Polymorphic kinase anchor proteins and nucleic acids encoding the same
|
FR2812658B1
(fr)
*
|
2000-08-01 |
2005-04-15 |
De Bruno Vandiere |
Procede d'analyse d'acides nucleiques
|
WO2002029109A2
(en)
*
|
2000-10-05 |
2002-04-11 |
Aclara Biosciences, Inc. |
Multiplexed differential displacement for nucleic acid determinations
|
CA2393374A1
(en)
*
|
2000-10-10 |
2002-04-18 |
Diversa Corporation |
High throughput or capillary-based screening for a bioactivity or biomolecule
|
ATE431355T1
(de)
*
|
2000-10-11 |
2009-05-15 |
Applera Corp |
Fluoreszierende nukleobasekonjugate mit anionische linker
|
ATE430194T1
(de)
*
|
2001-02-02 |
2009-05-15 |
Allvivo Inc |
Endgruppenaktivierte polymere mit oligonucleotid- liganden
|
EP1373573B1
(de)
*
|
2001-03-09 |
2013-10-02 |
TrovaGene, Inc. |
Konjugatsonden und optischer nachweis von analyten
|
EP1386002A4
(de)
*
|
2001-04-16 |
2006-11-08 |
Applera Corp |
Verfahren und zusammensetzungen zur nukleotidanalyse
|
US6743905B2
(en)
*
|
2001-04-16 |
2004-06-01 |
Applera Corporation |
Mobility-modified nucleobase polymers and methods of using same
|
JP2005505749A
(ja)
|
2001-05-21 |
2005-02-24 |
アクララ バイオサイエンシーズ, インコーポレイテッド |
タンパク質を分析するための方法および組成物
|
HUP0501021A3
(en)
|
2001-05-21 |
2006-06-28 |
Aclara Biosciences Inc Mountai |
Methods and compositions for analyzing proteins
|
AU2002344221A1
(en)
*
|
2001-05-26 |
2002-12-09 |
Aclara Biosciences, Inc. |
Catalytic amplification of multiplexed assay signals
|
US20030124592A1
(en)
*
|
2001-10-24 |
2003-07-03 |
Bioprofile, Llc |
Methods for detecting genetic haplotypes by interaction with probes
|
US7045311B2
(en)
*
|
2001-10-25 |
2006-05-16 |
Monogram Biosciences, Inc. |
Whole cell assay systems for cell surface proteases
|
CN1166422C
(zh)
*
|
2001-11-05 |
2004-09-15 |
北京源德生物医学工程股份有限公司 |
用于体外高能聚焦超声波治疗机的坐位架
|
US20040067512A1
(en)
*
|
2001-11-09 |
2004-04-08 |
Neurogenetics, Inc. |
Single nucleotide polymorphisms and mutations on Alpha-2-Macroglobulin
|
US20050053939A1
(en)
*
|
2001-11-09 |
2005-03-10 |
Ahmed Chenna |
Methods and compositions for enhancing detection in determinations employing cleavable electrophoretic tag reagents
|
AU2002364894A1
(en)
*
|
2001-11-09 |
2003-06-30 |
Neurogenetics, Inc. |
Single nucleotide polymorphisms and mutations on alpha-2-macroglobulin
|
US20030165935A1
(en)
|
2001-11-21 |
2003-09-04 |
Vann Charles S. |
Digital assay
|
EP1465998A2
(de)
|
2002-01-08 |
2004-10-13 |
Bayer HealthCare AG |
Herz-kreislauf-erkrankung und medikamentenwirkung voraussagende einzelnukleotid-polymorphismen
|
EP1478765A4
(de)
*
|
2002-03-05 |
2006-12-06 |
Aclara Biosciences Inc |
Multiplex-analyse mit membrangebundenen sensibilisatoren
|
US20030177380A1
(en)
*
|
2002-03-18 |
2003-09-18 |
Woods Stanley P. |
Devices for storing array data and methods of using the same
|
JP2003294742A
(ja)
*
|
2002-03-29 |
2003-10-15 |
Inst Of Physical & Chemical Res |
ハイブリダイゼーション用基板及びその使用方法
|
AU2003228809A1
(en)
|
2002-05-03 |
2003-11-17 |
Sequenom, Inc. |
Kinase anchor protein muteins, peptides thereof, and related methods
|
US20040229299A1
(en)
*
|
2002-05-21 |
2004-11-18 |
Badal M. Youssouf |
Intracellular complexes as biomarkers
|
US7402397B2
(en)
*
|
2002-05-21 |
2008-07-22 |
Monogram Biosciences, Inc. |
Detecting and profiling molecular complexes
|
US20040229380A1
(en)
*
|
2002-05-21 |
2004-11-18 |
Po-Ying Chan-Hui |
ErbB heterodimers as biomarkers
|
US20040229294A1
(en)
*
|
2002-05-21 |
2004-11-18 |
Po-Ying Chan-Hui |
ErbB surface receptor complexes as biomarkers
|
US20040229293A1
(en)
*
|
2002-05-21 |
2004-11-18 |
Po-Ying Chan-Hui |
Surface receptor complexes as biomarkers
|
US20040175765A1
(en)
*
|
2002-07-05 |
2004-09-09 |
Sharat Singh |
Cell-screening assay and composition
|
DE60329194D1
(de)
|
2002-07-25 |
2009-10-22 |
Aclara Biosciences Inc |
Nachweis der rezeptoroligomerisierung
|
EP2385137A1
(de)
|
2002-07-31 |
2011-11-09 |
University of Southern California |
Polymorphismen zur Vorhersage des Krankheits- und Behandlungsausgangs
|
US7381317B2
(en)
|
2002-08-12 |
2008-06-03 |
Beckman Coulter, Inc. |
Methods and compositions for capillary electrophoresis (CE)
|
CA2499360A1
(en)
|
2002-09-19 |
2004-04-01 |
Applera Corporation |
Methods and compositions for detecting targets
|
US20040235005A1
(en)
*
|
2002-10-23 |
2004-11-25 |
Ernest Friedlander |
Methods and composition for detecting targets
|
US20040091850A1
(en)
*
|
2002-11-08 |
2004-05-13 |
Travis Boone |
Single cell analysis of membrane molecules
|
US20060141475A1
(en)
*
|
2002-11-19 |
2006-06-29 |
Applera Corporation |
Polynucleotide sequence detection assays and analysis
|
WO2004046344A2
(en)
*
|
2002-11-19 |
2004-06-03 |
Applera Corporation |
Polynucleotide sequence detection assays
|
AU2003298672A1
(en)
*
|
2002-11-19 |
2005-01-28 |
Singulex, Inc. |
Detection of target molecules through interaction with probes
|
WO2005001129A2
(en)
*
|
2003-06-06 |
2005-01-06 |
Applera Corporation |
Mobility cassettes
|
US7402398B2
(en)
*
|
2003-07-17 |
2008-07-22 |
Monogram Biosciences, Inc. |
Measuring receptor homodimerization
|
US20090088982A1
(en)
*
|
2003-07-31 |
2009-04-02 |
Fukushima Noelle H |
Co-detection of single polypeptide and polynucleotide molecules
|
WO2005019470A2
(en)
*
|
2003-08-11 |
2005-03-03 |
Monogram Biosciences, Inc. |
Detecting and profiling molecular complexes
|
WO2005029041A2
(en)
*
|
2003-09-19 |
2005-03-31 |
Applera Corporation |
High density sequence detection methods and apparatus
|
US7570443B2
(en)
|
2003-09-19 |
2009-08-04 |
Applied Biosystems, Llc |
Optical camera alignment
|
EP1680666A4
(de)
*
|
2003-10-27 |
2008-03-26 |
Monogram Biosciences Inc |
Nachweisen von menschlichen antitherapeutischen antikörpern
|
US20050094807A1
(en)
*
|
2003-11-04 |
2005-05-05 |
John Silzel |
Accuracy array assay system and method
|
CA2552815A1
(en)
*
|
2004-01-10 |
2005-07-21 |
Bayer Healthcare Llc |
Haplotypes and polymorphisms linked to human thiopurine s-methyltransferase deficiencies
|
EP1727913B8
(de)
*
|
2004-03-24 |
2009-08-19 |
Applied Biosystems, LLC |
Ligation und amplifikationsreaktionen zur bestimmung von zielmolekülen
|
US20050255485A1
(en)
*
|
2004-05-14 |
2005-11-17 |
Livak Kenneth J |
Detection of gene duplications
|
EP2290076B1
(de)
|
2004-05-28 |
2015-03-25 |
Asuragen, Inc. |
Verfahren und Zusammensetzungen mit MicroRNA
|
US20060003337A1
(en)
*
|
2004-06-30 |
2006-01-05 |
John Brandis |
Detection of small RNAS
|
US20060115827A1
(en)
|
2004-07-01 |
2006-06-01 |
University Of Southern California |
Genetic markers for predicting disease and treatment outcome
|
WO2006137941A2
(en)
|
2004-11-12 |
2006-12-28 |
Ambion, Inc. |
Methods and compositions involving mirna and mirna inhibitor molecules
|
EP1856280A4
(de)
*
|
2005-01-12 |
2009-09-09 |
Applera Corp |
Zusammensetzungen, verfahren und kits zur selektiven verstärkung von nukleinsäuren
|
EP1869213A4
(de)
|
2005-03-14 |
2008-05-14 |
Univ Leland Stanford Junior |
Verfahren und zusammensetzungen zur bewertung der haltbarkeit eines pfropfs im körper eines empfängers fester organtransplantate
|
EP1856293A2
(de)
*
|
2005-03-16 |
2007-11-21 |
Compass Genetics, Llc |
Verfahren und zusammensetzungen zum ablesen von assays auf mehrfachen analytischen plattformen
|
JP2008535518A
(ja)
|
2005-04-14 |
2008-09-04 |
アプレラ コーポレイション |
プソイドイソシトシン核酸塩基誘導体を含む3’改変オリゴヌクレオチド、およびプライマーまたはプローブとしてのその適用
|
EP1731620A1
(de)
|
2005-06-07 |
2006-12-13 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Methode zur Diagnose von Immun-Transplantatstoleranz
|
US20070087360A1
(en)
*
|
2005-06-20 |
2007-04-19 |
Boyd Victoria L |
Methods and compositions for detecting nucleotides
|
US20070014699A1
(en)
*
|
2005-06-23 |
2007-01-18 |
Beckman Coulter, Inc, |
Methods and apparatus for improving the sensitivity of capillary zone electrophoresis
|
WO2007011946A2
(en)
*
|
2005-07-15 |
2007-01-25 |
Applera Corporation |
Detection of nucleic acid amplification
|
US20070026439A1
(en)
*
|
2005-07-15 |
2007-02-01 |
Applera Corporation |
Fluid processing device and method
|
CA2620338A1
(en)
|
2005-09-22 |
2007-04-12 |
Inserm (Institut De La Sante Et De La Recherche Medicale) |
Methods of using il-21
|
US20070202515A1
(en)
*
|
2005-10-12 |
2007-08-30 |
Pathologica, Llc. |
Promac signature application
|
US7807364B2
(en)
|
2006-03-03 |
2010-10-05 |
University Of Southern California |
Angiogenesis pathway gene polymorphisms for therapy selection
|
US20070215472A1
(en)
*
|
2006-03-15 |
2007-09-20 |
Slater Gary W |
Electroosmotic flow for end labelled free solution electrophoresis
|
US20070218494A1
(en)
*
|
2006-03-17 |
2007-09-20 |
Gary Slater |
Branched polymer lables as drag-tags in free solution electrophoresis
|
US7759062B2
(en)
*
|
2006-06-09 |
2010-07-20 |
Third Wave Technologies, Inc. |
T-structure invasive cleavage assays, consistent nucleic acid dispensing, and low level target nucleic acid detection
|
EP3796002B1
(de)
|
2006-07-14 |
2023-11-22 |
The Regents of The University of California |
Krebsbiomarker und verfahren zur verwendung davon
|
EP2487240B1
(de)
|
2006-09-19 |
2016-11-16 |
Interpace Diagnostics, LLC |
Mikro-RNA, die differentiell in Pankreaserkrankungen exprimiert sind, und ihre Verwendung
|
EP2145001A2
(de)
|
2006-09-19 |
2010-01-20 |
Asuragen, Inc. |
Von mir-15, mir-26, mir -31,mir -145, mir-147, mir-188, mir-215, mir-216 mir-331, mmu-mir-292-3p regulierte gene und stoffwechselwege als ziele für einen therapeutischen eingriff
|
US20080145898A1
(en)
*
|
2006-12-14 |
2008-06-19 |
Applera Corporation |
Sequencing methods
|
US8114599B2
(en)
|
2006-12-19 |
2012-02-14 |
Northwestern University |
Compositions and methods for free-solution conjugate nucleic acid analysis
|
US8435752B2
(en)
*
|
2007-01-18 |
2013-05-07 |
University Of Southern California |
Gene polymorphisms predictive for dual TKI therapy
|
US8278061B2
(en)
|
2007-01-18 |
2012-10-02 |
University Of Southern California |
Polymorphisms in the EGFR pathway as markers for cancer treatment
|
AU2008210421B2
(en)
|
2007-01-30 |
2014-03-13 |
Pharmacyclics Llc |
Methods for determining cancer resistance to histone deacetylase inhibitors
|
FI20075124A0
(fi)
*
|
2007-02-21 |
2007-02-21 |
Valtion Teknillinen |
Menetelmä ja testikitti nukleotidivariaatioiden toteamiseksi
|
EP1961825A1
(de)
|
2007-02-26 |
2008-08-27 |
INSERM (Institut National de la Santé et de la Recherche Medicale) |
Verfahren zur Vorhersage des Auftretens von Metastasen bei Brustkrebspatienten
|
EP2118322A2
(de)
|
2007-03-13 |
2009-11-18 |
Amgen Inc. |
K-ras- und b-baf-mutationen und anti-egfr-antikörpertherapie
|
EP2121989B2
(de)
|
2007-03-13 |
2022-03-09 |
Amgen Inc. |
K-ras-mutationen und anti-egfr-antikörpertherapie
|
EP3543357A1
(de)
|
2007-05-08 |
2019-09-25 |
Trustees of Boston University |
Chemische funktionalisierung von festkörpernanoporen und nanoporenarrays und anwendungen davon
|
US8008010B1
(en)
|
2007-06-27 |
2011-08-30 |
Applied Biosystems, Llc |
Chimeric oligonucleotides for ligation-enhanced nucleic acid detection, methods and compositions therefor
|
WO2009070772A1
(en)
*
|
2007-11-27 |
2009-06-04 |
Monogram Biosciences, Inc. |
Enhanced method for detecting and/or quantifying an analyte in a sample
|
US8658379B2
(en)
|
2008-01-29 |
2014-02-25 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Follistatin-like protein-1 as a biomarker for sepsis
|
WO2009097424A1
(en)
*
|
2008-01-29 |
2009-08-06 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Fstl-1 as a biomarker of inflammation
|
EP2113574A1
(de)
|
2008-04-28 |
2009-11-04 |
Biotype AG |
Stoffe und Verfahren für Profilierungstest auf DNA-Basis
|
US8258111B2
(en)
|
2008-05-08 |
2012-09-04 |
The Johns Hopkins University |
Compositions and methods related to miRNA modulation of neovascularization or angiogenesis
|
JP5892791B2
(ja)
|
2008-05-14 |
2016-03-23 |
ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. |
適応免疫における免疫調節物質の効果をモニターするための方法およびキット
|
WO2009145802A1
(en)
*
|
2008-05-30 |
2009-12-03 |
The Trustess Of Columbia University In The City Of New York |
Systems and methods for integrating a single dna molecule into a molecular electronic device
|
US8208909B2
(en)
|
2008-06-02 |
2012-06-26 |
West Corporation |
System, apparatus and method for availing a mobile call of address information
|
US20110201519A1
(en)
|
2008-08-18 |
2011-08-18 |
Sarwal Minnie M |
Methods and Compositions for Determining a Graft Tolerant Phenotype in a Subject
|
WO2010065517A1
(en)
|
2008-12-01 |
2010-06-10 |
The Trustees Of Columbia University In The City Of New York |
Electromechanical devices and methods for fabrication of the same
|
DE102009010563A1
(de)
|
2009-02-16 |
2010-08-26 |
Matthias W. Engel |
Vorrichtung zum Nachweis von Analyten in Körperflüssigkeiten
|
WO2010123626A1
(en)
|
2009-04-24 |
2010-10-28 |
University Of Southern California |
Cd133 polymorphisms and expression predict clinical outcome in patients with cancer
|
WO2011004345A1
(en)
|
2009-07-09 |
2011-01-13 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Upstream binding protein 1 polymorphisms and their use for prognosing or diagnosing arterial blood pressure
|
EA025172B9
(ru)
|
2009-08-22 |
2017-01-30 |
Дзе Борд Оф Трастиз Оф Дзе Лелэнд Стэнфорд Джуниор Юниверсити |
Способ оценки способности достижения одним или более эмбрионами человека стадии бластоцисты
|
AU2010301128B2
(en)
|
2009-09-30 |
2014-09-18 |
Quantapore, Inc. |
Ultrafast sequencing of biological polymers using a labeled nanopore
|
JP2013510564A
(ja)
|
2009-11-13 |
2013-03-28 |
パンガエア ビオテック、ソシエダッド、リミターダ |
肺癌におけるチロシンキナーゼ阻害剤に対する応答を予測するための分子バイオマーカー
|
US9290813B2
(en)
|
2009-12-02 |
2016-03-22 |
The Board Of Trustees Of The Leland Stanford Junior University |
Biomarkers for determining an allograft tolerant phenotype
|
GB0922085D0
(en)
|
2009-12-17 |
2010-02-03 |
Cambridge Entpr Ltd |
Cancer diagnosis and treatment
|
US20120288861A1
(en)
|
2009-12-21 |
2012-11-15 |
Heinz-Josef Lenz |
Germline polymorphisms in the sparc gene associated with clinical outcome in gastric cancer
|
WO2011085334A1
(en)
|
2010-01-11 |
2011-07-14 |
University Of Southern California |
Cd44 polymorphisms predict clinical outcome in patients with gastric cancer
|
TWI518325B
(zh)
|
2010-02-04 |
2016-01-21 |
自治醫科大學 |
對alk抑制劑具有先抗性或後抗性癌症的識別、判斷和治療
|
EP3214174B1
(de)
|
2010-03-04 |
2019-10-16 |
InteRNA Technologies B.V. |
Mirna-molekül, das über seine quelle definiert ist, und seine diagnostischen und therapeutischen verwendungen bei mit emt assoziierten krankheiten
|
CA2795677A1
(en)
|
2010-04-19 |
2011-10-27 |
The Procter & Gamble Company |
Combined energy and topical composition application for regulating the condition of mammalian skin
|
EP2561092A1
(de)
|
2010-04-19 |
2013-02-27 |
The Procter & Gamble Company |
Genetische signaturen und gen-chips zur verabreichung von elektrisch geleitetem funkfrequenzstrom an die haut sowie verfahren und behandlungen im zusammenhang damit
|
WO2011139721A1
(en)
|
2010-04-27 |
2011-11-10 |
The Regents Of The University Of California |
Cancer biomarkers and methods of use thereof
|
US10240194B2
(en)
*
|
2010-05-13 |
2019-03-26 |
Gen9, Inc. |
Methods for nucleotide sequencing and high fidelity polynucleotide synthesis
|
WO2011146725A1
(en)
|
2010-05-19 |
2011-11-24 |
Bayer Healthcare Llc |
Biomarkers for a multikinase inhibitor
|
WO2012003330A2
(en)
|
2010-06-30 |
2012-01-05 |
Stratos Genomics, Inc |
Multiplexed identification of nucleic acid sequences
|
EP3369817A1
(de)
|
2010-07-06 |
2018-09-05 |
InteRNA Technologies B.V. |
Mirna und ihre diagnostischen und therapeutischen verwendungen bei erkrankungen und zuständen im zusammenhang mit melanomen oder bei erkrankungen und zuständen mit einem aktivierten braf-pfad
|
WO2012019099A2
(en)
|
2010-08-05 |
2012-02-09 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Follistatin-like-protein-1 as a biomarker for inflammatory disorders
|
JP2013537045A
(ja)
|
2010-09-15 |
2013-09-30 |
アルマック ダイアグノスティックス リミテッド |
癌のための分子診断試験
|
WO2012051301A1
(en)
|
2010-10-12 |
2012-04-19 |
President And Fellows Of Harvard College |
Methods for identifying modulators of triglyceride metabolism, for modulating triglyceride metabolism and for identifying subjects at risk for abnormal triglyceride metabolism
|
JP6155194B2
(ja)
|
2010-11-17 |
2017-06-28 |
インターペース ダイアグノスティックス リミテッド ライアビリティ カンパニー |
良性甲状腺新生物と悪性甲状腺新生物を区別するためのバイオマーカーとしてのmiRNA
|
EP2474617A1
(de)
|
2011-01-11 |
2012-07-11 |
InteRNA Technologies BV |
MIR zur Behandlung von Neoangiogenese
|
US8486717B2
(en)
|
2011-01-18 |
2013-07-16 |
Symbolics, Llc |
Lateral flow assays using two dimensional features
|
EP2492688A1
(de)
|
2011-02-23 |
2012-08-29 |
Pangaea Biotech, S.A. |
Molekulare Biomarker zur Vorhersage der Reaktion auf die Antitumorbehandlung bei Lungenkrebs
|
EP2678675B1
(de)
|
2011-02-23 |
2017-10-11 |
The Board of Trustees of the Leland Stanford Junior University |
Verfahren zum nachweis von aneuploidie in menschlichen embryonen
|
WO2012158238A2
(en)
|
2011-02-28 |
2012-11-22 |
University Of Iowa Research Foundation |
Anti-müllerian hormone changes in pregnancy and prediction ofadverse pregnancy outcomes and gender
|
EP2710144B1
(de)
|
2011-05-19 |
2020-10-07 |
Agena Bioscience, Inc. |
Verfahren zur multiplex-identifizierung von nukleinsäuren
|
SG10201604497UA
(en)
|
2011-06-02 |
2016-07-28 |
Almac Diagnostics Ltd |
Molecular Diagnostic Test For Cancer
|
US9644241B2
(en)
|
2011-09-13 |
2017-05-09 |
Interpace Diagnostics, Llc |
Methods and compositions involving miR-135B for distinguishing pancreatic cancer from benign pancreatic disease
|
WO2013063519A1
(en)
|
2011-10-26 |
2013-05-02 |
Asuragen, Inc. |
Methods and compositions involving mirna expression levels for distinguishing pancreatic cysts
|
US20130142728A1
(en)
|
2011-10-27 |
2013-06-06 |
Asuragen, Inc. |
Mirnas as diagnostic biomarkers to distinguish benign from malignant thyroid tumors
|
CN104080926B
(zh)
|
2011-10-28 |
2019-04-23 |
米伦纽姆医药公司 |
对nedd8活化酶(nae)抑制剂的反应的生物标记
|
JP6397765B2
(ja)
|
2011-11-11 |
2018-09-26 |
ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. |
プロテアソーム阻害剤に応答するバイオマーカー
|
CA2855368A1
(en)
|
2011-11-11 |
2013-05-16 |
Millennium Pharmaceuticals, Inc. |
Biomarkers of response to proteasome inhibitors
|
WO2013087789A1
(en)
|
2011-12-13 |
2013-06-20 |
Glykos Finland Ltd. |
Antibody isoform arrays and methods thereof
|
US20150152499A1
(en)
|
2012-07-03 |
2015-06-04 |
Interna Technologies B.V. |
Diagnostic portfolio and its uses
|
EP2875131B1
(de)
|
2012-07-18 |
2018-03-14 |
Siemens Healthcare Diagnostics Inc. |
Verfahren zur normalisierung von biologischen proben
|
US9874556B2
(en)
|
2012-07-18 |
2018-01-23 |
Symbolics, Llc |
Lateral flow assays using two dimensional features
|
EP2893035B1
(de)
|
2012-09-06 |
2018-05-02 |
Life Technologies Corporation |
Multiplex-y-str-analyse
|
US10662477B2
(en)
|
2012-10-01 |
2020-05-26 |
Millennium Pharmaceuticals, Inc. |
Biomarkers and methods to predict response to inhibitors and uses thereof
|
US20140100124A1
(en)
|
2012-10-04 |
2014-04-10 |
Asuragen, Inc. |
Diagnostic mirnas for differential diagnosis of incidental pancreatic cystic lesions
|
CA2889765C
(en)
|
2012-10-26 |
2021-06-22 |
Minna D. BALBAS |
Androgen receptor variants and methods for making and using
|
US9651539B2
(en)
|
2012-10-28 |
2017-05-16 |
Quantapore, Inc. |
Reducing background fluorescence in MEMS materials by low energy ion beam treatment
|
CA2892361A1
(en)
|
2012-11-28 |
2014-06-05 |
Merck Sharp & Dohme Corp. |
Use of a wee1 inhibitor for treating a cancer characterized by low pkmyt1 expression levels
|
CN105102631A
(zh)
|
2012-12-03 |
2015-11-25 |
阿尔玛克诊断有限公司 |
用于癌症的分子诊断测试
|
CA2905949A1
(en)
|
2013-03-15 |
2014-09-25 |
Baylor Research Institute |
Ulcerative colitis (uc)-associated colorectal neoplasia markers
|
EP3404116B1
(de)
|
2013-03-15 |
2022-10-19 |
The University of Chicago |
Verfahren und zusammensetzungen in zusammenhang mit t-zell aktivität
|
US9868992B2
(en)
|
2013-03-15 |
2018-01-16 |
Baylor Research Institute |
Tissue and blood-based miRNA biomarkers for the diagnosis, prognosis and metastasis-predictive potential in colorectal cancer
|
EP2805769A1
(de)
|
2013-05-24 |
2014-11-26 |
European Molecular Biology Laboratory |
Verfahren zur nanoskaligen Einzelzellenanalyse
|
WO2014190322A2
(en)
|
2013-05-24 |
2014-11-27 |
Quantapore, Inc. |
Nanopore-based nucleic acid analysis with mixed fret detection
|
WO2014201155A1
(en)
|
2013-06-11 |
2014-12-18 |
Courtagen Life Sciences, Inc. |
Methods and kits for treating and classifying individuals at risk of or suffering from trap1 change-of-function
|
TWI695067B
(zh)
|
2013-08-05 |
2020-06-01 |
美商扭轉生物科技有限公司 |
重新合成之基因庫
|
WO2015038978A1
(en)
|
2013-09-13 |
2015-03-19 |
Symbolics, Llc |
Lateral flow assays using two dimensional test and control signal readout patterns
|
US20160304969A1
(en)
|
2013-12-17 |
2016-10-20 |
Merck Sharp & Dohme Corp. |
Ifn-gamma gene signature biomarkers of tumor response to pd-1 antagonists
|
GB201409479D0
(en)
|
2014-05-28 |
2014-07-09 |
Almac Diagnostics Ltd |
Molecular diagnostic test for cancer
|
EP3126520B1
(de)
|
2014-04-04 |
2021-06-09 |
Amgen, Inc. |
Amg-337 zur behandlung von krebs mit einer ampflizierung von met
|
US20180363070A9
(en)
|
2014-08-12 |
2018-12-20 |
Univ Wayne State |
Systems and methods to detect stem cell stress and uses thereof
|
US9885079B2
(en)
|
2014-10-10 |
2018-02-06 |
Quantapore, Inc. |
Nanopore-based polymer analysis with mutually-quenching fluorescent labels
|
GB201418892D0
(en)
*
|
2014-10-23 |
2014-12-10 |
Proqr Therapeutics B V |
DNA editing
|
WO2016065339A1
(en)
|
2014-10-24 |
2016-04-28 |
Quantapore, Inc. |
Efficient optical analysis of polymers using arrays of nanostructures
|
EP3227687A4
(de)
|
2014-12-05 |
2018-10-24 |
Prelude, Inc. |
Dcis-wiederauftreten und invasiver brustkrebs
|
WO2016094377A1
(en)
|
2014-12-09 |
2016-06-16 |
Merck Sharp & Dohme Corp. |
System and methods for deriving gene signature biomarkers of response to pd-1 antagonists
|
CA2975855A1
(en)
|
2015-02-04 |
2016-08-11 |
Twist Bioscience Corporation |
Compositions and methods for synthetic gene assembly
|
US10669304B2
(en)
|
2015-02-04 |
2020-06-02 |
Twist Bioscience Corporation |
Methods and devices for de novo oligonucleic acid assembly
|
EP3839510A3
(de)
|
2015-04-17 |
2021-08-25 |
Merck Sharp & Dohme Corp. |
Blutbasierte biomarker der tumorempfindlichkeit gegen pd-1-antagonisten
|
US9981239B2
(en)
|
2015-04-21 |
2018-05-29 |
Twist Bioscience Corporation |
Devices and methods for oligonucleic acid library synthesis
|
WO2016172579A1
(en)
|
2015-04-24 |
2016-10-27 |
Agena Bioscience, Inc, |
Multiplex methods for detection and quantification of minor variants
|
CN107406882B
(zh)
|
2015-04-24 |
2022-03-01 |
基纳生物技术有限公司 |
用于次要等位基因和多态性的鉴定和定量的多重化方法
|
GB201512869D0
(en)
|
2015-07-21 |
2015-09-02 |
Almac Diagnostics Ltd |
Gene signature for minute therapies
|
KR20180050411A
(ko)
|
2015-09-18 |
2018-05-14 |
트위스트 바이오사이언스 코포레이션 |
올리고핵산 변이체 라이브러리 및 그의 합성
|
CN108698012A
(zh)
|
2015-09-22 |
2018-10-23 |
特韦斯特生物科学公司 |
用于核酸合成的柔性基底
|
EP3384077A4
(de)
|
2015-12-01 |
2019-05-08 |
Twist Bioscience Corporation |
Funktionalisierte oberflächen und herstellung davon
|
CN109073654A
(zh)
|
2016-04-20 |
2018-12-21 |
苏州爱尔迪思生物科技有限公司 |
用于预测早产的方法和组合物
|
WO2017197573A1
(en)
|
2016-05-17 |
2017-11-23 |
Ldx Prognostics Limited Co. |
Methods and compositions for providing preeclampsia assessment
|
JP2019522983A
(ja)
|
2016-07-05 |
2019-08-22 |
クアンタポール, インコーポレイテッド |
光学ベースのナノポア配列決定
|
AU2017315294B2
(en)
|
2016-08-22 |
2023-12-21 |
Twist Bioscience Corporation |
De novo synthesized nucleic acid libraries
|
US10417457B2
(en)
|
2016-09-21 |
2019-09-17 |
Twist Bioscience Corporation |
Nucleic acid based data storage
|
CN110366613A
(zh)
|
2016-12-16 |
2019-10-22 |
特韦斯特生物科学公司 |
免疫突触的变体文库及其合成
|
US11550939B2
(en)
|
2017-02-22 |
2023-01-10 |
Twist Bioscience Corporation |
Nucleic acid based data storage using enzymatic bioencryption
|
CN110913865A
(zh)
|
2017-03-15 |
2020-03-24 |
特韦斯特生物科学公司 |
免疫突触的变体文库及其合成
|
EP3607065B1
(de)
*
|
2017-04-06 |
2023-03-15 |
Qing Wang |
Verfahren und kit zum aufbau einer nukleinsäurebibliothek
|
WO2018186947A1
(en)
*
|
2017-04-06 |
2018-10-11 |
MyOmicsDx, Inc |
Method and kit for targeted enrichment of nucleic acids
|
EP3615934A1
(de)
|
2017-04-28 |
2020-03-04 |
Merck Sharp & Dohme Corp. |
Biomarker für krebstherapeutika
|
WO2018231864A1
(en)
|
2017-06-12 |
2018-12-20 |
Twist Bioscience Corporation |
Methods for seamless nucleic acid assembly
|
KR102628876B1
(ko)
|
2017-06-12 |
2024-01-23 |
트위스트 바이오사이언스 코포레이션 |
심리스 핵산 어셈블리를 위한 방법
|
CN111566125A
(zh)
|
2017-09-11 |
2020-08-21 |
特韦斯特生物科学公司 |
Gpcr结合蛋白及其合成
|
CA3079613A1
(en)
|
2017-10-20 |
2019-04-25 |
Twist Bioscience Corporation |
Heated nanowells for polynucleotide synthesis
|
WO2019086603A1
(en)
|
2017-11-03 |
2019-05-09 |
Interna Technologies B.V. |
Mirna molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation
|
US20200377958A1
(en)
|
2017-12-01 |
2020-12-03 |
Millennium Pharmaceuticals, Inc. |
Biomarkers and methods for treatment with nae inhibitors
|
CA3088911A1
(en)
|
2018-01-04 |
2019-07-11 |
Twist Bioscience Corporation |
Dna-based digital information storage
|
US20210386829A1
(en)
|
2018-05-04 |
2021-12-16 |
The Broad Institute, Inc. |
Compositions and methods for modulating cgrp signaling to regulate innate lymphoid cell inflammatory responses
|
AU2019270243A1
(en)
|
2018-05-18 |
2021-01-07 |
Twist Bioscience Corporation |
Polynucleotides, reagents, and methods for nucleic acid hybridization
|
WO2020036926A1
(en)
|
2018-08-17 |
2020-02-20 |
Cellecta, Inc. |
Multiplex preparation of barcoded gene specific dna fragments
|
EP3850368A4
(de)
|
2018-09-14 |
2022-11-23 |
Prelude Corporation |
Verfahren zur auswahl zur behandlung von subjekten mit risiko auf invasiven brustkrebs
|
US20220401460A1
(en)
|
2018-10-10 |
2022-12-22 |
Dana-Farber Cancer Institute, Inc. |
Modulating resistance to bcl-2 inhibitors
|
KR20210143766A
(ko)
|
2019-02-26 |
2021-11-29 |
트위스트 바이오사이언스 코포레이션 |
Glp1 수용체에 대한 변이체 핵산 라이브러리
|
KR20210144698A
(ko)
|
2019-02-26 |
2021-11-30 |
트위스트 바이오사이언스 코포레이션 |
항체 최적화를 위한 변이 핵산 라이브러리
|
JP2022521797A
(ja)
|
2019-02-27 |
2022-04-12 |
マデラ セラピューティクス,エルエルシー |
イミプリドン様薬剤に対する薬物反応のバイオマーカとしてのカゼイン分解プロテアーゼpの機能の使用
|
WO2020186101A1
(en)
|
2019-03-12 |
2020-09-17 |
The Broad Institute, Inc. |
Detection means, compositions and methods for modulating synovial sarcoma cells
|
WO2020186235A1
(en)
|
2019-03-14 |
2020-09-17 |
The Broad Institute, Inc. |
Compositions and methods for modulating cgrp signaling to regulate intestinal innate lymphoid cells
|
EP3942023A1
(de)
|
2019-03-18 |
2022-01-26 |
The Broad Institute, Inc. |
Zusammensetzungen und verfahren zur modulation metabolischer regulatoren der t-zell-pathogenität
|
US20220152148A1
(en)
|
2019-03-18 |
2022-05-19 |
The Broad Institute, Inc. |
Modulation of type 2 immunity by targeting clec-2 signaling
|
WO2020210521A2
(en)
|
2019-04-12 |
2020-10-15 |
The Regents Of The University Of California |
Compositions and methods for increasing muscle mass and oxidative metabolism
|
US11332738B2
(en)
|
2019-06-21 |
2022-05-17 |
Twist Bioscience Corporation |
Barcode-based nucleic acid sequence assembly
|
US20220282333A1
(en)
|
2019-08-13 |
2022-09-08 |
The General Hospital Corporation |
Methods for predicting outcomes of checkpoint inhibition and treatment thereof
|
CN110470760A
(zh)
*
|
2019-08-16 |
2019-11-19 |
谱尼测试集团吉林有限公司 |
塑料制品中聚乳酸含量的检测方法
|
US11793787B2
(en)
|
2019-10-07 |
2023-10-24 |
The Broad Institute, Inc. |
Methods and compositions for enhancing anti-tumor immunity by targeting steroidogenesis
|
US11844800B2
(en)
|
2019-10-30 |
2023-12-19 |
Massachusetts Institute Of Technology |
Methods and compositions for predicting and preventing relapse of acute lymphoblastic leukemia
|
WO2021127610A1
(en)
|
2019-12-20 |
2021-06-24 |
EDWARD Via COLLEGE OF OSTEOPATHIC MEDICINE |
Cancer signatures, methods of generating cancer signatures, and uses thereof
|
WO2022192419A2
(en)
|
2021-03-09 |
2022-09-15 |
Massachusetts Institute Of Technology |
Methods of treating inflammatory bowel disease (ibd) with anti- tnf-blockade
|
WO2023158732A1
(en)
|
2022-02-16 |
2023-08-24 |
Dana-Farber Cancer Institute, Inc. |
Methods for decreasing pathologic alpha-synuclein using agents that modulate fndc5 or biologically active fragments thereof
|
WO2024028794A1
(en)
|
2022-08-02 |
2024-02-08 |
Temple Therapeutics BV |
Methods for treating endometrial and ovarian hyperproliferative disorders
|